David W. Carley

Director Técnico/Científico/I+D en Pier Pharmaceuticals, Inc. .

Health Technology

Consumer Services

Finance

Cargos activos de David W. Carley

Empresas	Cargo	Inicio	Fin
Pier Pharmaceuticals, Inc. Pier Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Pier Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company which develops a pharmacologic treatment for obstructive sleep apnea (OSA). It develops Dronabinol a synthetic derivative of the naturally occurring substance in the cannabis plant, namely delta-9-tetrahydrocannabinol, otherwise known as delta-9 THC. The company was founded in 2007 and is headquartered in Louiseville, CO.	Director/Miembro de la Junta	29/06/2011	-
	Director Técnico/Científico/I+D	29/06/2011	-
University of Illinois	Corporate Officer/Principal	29/06/2011	-

Empresas	Cargo	Inicio	Fin
RESPIRERX PHARMACEUTICALS INC.	Director/Miembro de la Junta	10/08/2012	-

Harvard University	Doctorate Degree
Massachusetts Institute of Technology	Graduate Degree

Internacional

Estados Unidos

Operativa

Sectorial

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	1
RESPIRERX PHARMACEUTICALS INC.	Health Technology

Empresas privadas	1
Pier Pharmaceuticals, Inc. Pier Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Pier Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company which develops a pharmacologic treatment for obstructive sleep apnea (OSA). It develops Dronabinol a synthetic derivative of the naturally occurring substance in the cannabis plant, namely delta-9-tetrahydrocannabinol, otherwise known as delta-9 THC. The company was founded in 2007 and is headquartered in Louiseville, CO.	Health Technology

Empresas privadas

Health Technology